Restricted Cash

9 Months Ended

Sep. 30, 2020

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]

Cash And Cash Equivalents Disclosure [Text Block]

Note 13 – Restricted Cash

The Company has restricted cash recorded in other assets related to proceeds from an inactive subsidiary of the Company which

previously executed separate settlement and release agreements with two of its insurance carriers for an original total value of $35.0

million.

 The proceeds of both settlements are restricted and can only be used to pay claims and costs of defense associated with the

subsidiary’s asbestos litigation. The proceeds of the settlement and release agreements have been deposited into interest bearing

accounts that earned less than $

0.1

 million in the nine months ended September 30, 2020, compared to $

0.2

 million in the nine months

ended September 30, 2019. The interest was offset by $

0.8

 million of payments during the nine months ended September 30, 2020,

compared to $

0.6

 million of payments in the nine months ended September 30, 2019. Due to the restricted nature of the proceeds, a

corresponding deferred credit was established in other non-current liabilities for an equal and offsetting amount, and will remain until

the restrictions lapse or the funds are exhausted via payments of claims and costs of defense.

The following table provides a reconciliation of cash, cash equivalents and restricted cash as of September 30, 2020 and 2019,

and December 31, 2019 and 2018:

September 30,

December 31,

2020

2019

2019

2018

Cash and cash equivalents

$

155,750

$

128,161

$

123,524

$

104,147

Restricted cash included in other current assets

82

460

353

—

Restricted cash included in other assets

18,901

19,839

19,678

20,278

Cash, cash equivalents and restricted cash

$

174,733

$

148,460

$

143,555

$

124,425